Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Option Care Health, Inc. (OPCH) SEC filings page brings together the company’s official regulatory disclosures, as filed with the U.S. Securities and Exchange Commission. These documents provide detailed insight into how the nation’s largest independent provider of home and alternate site infusion services reports its financial condition, capital structure, governance changes and material agreements.
Investors can use this page to access current and historical 10-K and 10-Q reports, which contain audited and interim financial statements, segment information, risk factor discussions and management’s analysis of the business. For Option Care Health, these filings complement its earnings press releases that discuss net revenue, net income, earnings per share and non-GAAP measures such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS, and they provide the underlying GAAP detail and reconciliations referenced in those releases.
The page also tracks Form 8-K filings, which Option Care Health uses to report material events. Recent examples include 8-Ks furnishing quarterly earnings press releases under Item 2.02, an 8-K describing a Fourth Amendment to the company’s Amended and Restated First Lien Credit Agreement under Item 1.01 and Item 2.03, and an 8-K outlining a Chief Financial Officer transition and related compensatory arrangements under Item 5.02. These filings explain changes to term loans and revolving credit facilities, leadership appointments and transitions, and other significant corporate actions.
Users interested in executive and director information can review proxy materials and governance-related filings, which describe board composition, executive compensation structures and incentive plans referenced in 8-K disclosures. For those monitoring potential insider activity, Form 4 and related ownership reports, when filed, show transactions by directors, officers and significant shareholders in OPCH stock.
To make this information more accessible, this page pairs real-time updates from the SEC’s EDGAR system with AI-powered summaries that highlight key points from lengthy filings. Instead of reading an entire credit agreement amendment or multi-hundred-page annual report, users can quickly see what changed in Option Care Health’s debt terms, how non-GAAP metrics reconcile to GAAP results, or what new risks and governance details have been disclosed, and then drill into the full documents as needed.
Option Care Health director Pate R. Carter reported an open-market sale of company stock. On February 27, 2026, Carter sold 30,287 shares of Option Care Health common stock at a weighted average price of $32.0474 per share in multiple trades, leaving 11,623 shares held directly.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported an open-market sale of 6,000 shares of common stock at
Option Care Health, Inc. Chief Operating Officer Luke Whitworth reported a tax-related share disposition. On this Form 4, he transferred 4,605 shares of common stock at $33.815 per share to cover tax withholding, rather than executing an open-market sale. After this transaction, he directly holds 169,589 common shares.
Option Care Health Chief Growth Officer reports tax-related share disposition
Christopher L. Grashoff, Chief Growth Officer of Option Care Health, Inc., disposed of 1,980 shares of common stock on a tax-withholding basis at $33.815 per share. After this tax-withholding disposition, he directly holds 44,092 Option Care Health common shares.
Option Care Health, Inc. general counsel and corporate secretary Collin Smyser reported a Form 4 showing a tax-withholding disposition of 2,210 shares of common stock on
Option Care Health, Inc. Chief Medical Officer Adewunmi Femi reported a Form 4 transaction involving a tax-withholding disposition of 1,627 shares of common stock at an indicated price of $33.815 per share on February 24, 2026. After this transaction, Femi directly owned 26,710 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Executive Officer John Charles Rademacher used company stock to cover taxes on
Option Care Health, Inc. executive Michael Bavaro, the Chief Human Resources Officer, reported a disposition of company stock related to taxes. On this Form 4, he used 1,354 shares of common stock at $33.815 per share to cover a tax liability. After this tax-withholding transaction, he directly owned 39,249 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Accounting Officer Nicole Maggio reported a tax-withholding disposition of company stock. On February 24, 2026, she used 975 shares of common stock, valued at $33.815 per share, to satisfy tax obligations. After this transaction, she directly owned 28,489 shares of Option Care Health common stock.